NCT01120340 - Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Diverticular Disease

Interventions

DRUG

mesalamine

mesalamine: 1.6 g/die for ten days/month until 24 months

OTHER

placebo

2 pills/day for ten days/month until 24 months

Trial Locations (17)

A.O. G. Salvini, Rho (MI)

Ospedale di Seriate, Seriate

Ospedale di Esine, Esine

Ospedale Maggiore, Crema

Ospedale di Desio, Desio

Ospedale di Garbagnate M.se, Garbagnate Milanese

Ospedale C. Borella, Giussano

Ospedale Civile, Legnano

Policlinico di Monza, Monza

Ospedale S. Antonio Abate, Gallarate

Azienda ULSS, Belluno

Poliambulanza, Brescia

Ospedale A. Manzoni, Lecco

Ospedale G. Bosco, Torino

Ospedale Maria Vittoria, Torino

Ospedale Molinette, Torino

Ospedale S. Chiara, Trento

All Listed Sponsors

lead

SOFAR S.p.A.

INDUSTRY